Opposing actions of angiotensins on angiogenesis

Life Sciences

Volumn 66, Issue 1, 1999, Pages 67-76

  Machado, Rosângela DP ^a   Santos, Robson AS ^a   Andrade, Silvia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiogenesis; Angiotensin II; Angiotensin (1 7); Wound healing

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN[1-7]; HEMOGLOBIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; HISTOLOGY; HORMONAL REGULATION; HORMONE INHIBITION; IMPLANTATION; MALE; MOUSE; NONHUMAN; VASCULAR TISSUE; WOUND HEALING;

ANIMALIA; MURINAE;

EID: 0033607368     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00562-7     Document Type: Article

References (44)

1. 1. D. Hanahan and J. Folkman, Cell 86 353-364 (1996).
2. 2. E.H. Sage, Trends Cell Biol 7 182-186 (1997).
3. 3. M.S. O'Reilly, L. Holmgren, Y. Shing, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage and J. Folkman, Cell 79 315-328 (1994).
4. 4. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen and J. Folkman, Cell 88 277-285 (1997).
5. 5. C. Clapp, J.A. Martial, R.C. Guzman, F. Rentier-Delrue and R.I. Weiner, Endocrinology 133 1292-1299 (1993).
6. 6. L.A. Fernandez, J. Twickler and A. Mead, Lab Clin Med 105 141-145 (1985).
7. 7. F.A.C. Le Noble, J.W.M. Hekking, H.W.M. Van Straaten, D.W. Slaaf and H.A.J. Struijker-Boudier, Eur J Pharmacol 195 305-306 (1991).
8. 8. D.E. Hu, C.R. Hiley and T.D.P. Fan, Br J Pharmacol 117 545-551 (1996).
9. 9. S.P. Andrade, C.C. Cardoso, R.D.P. Machado and W.T. Beraldo, Int J Microcirc Clin Exp 16 302-307 (1996).
10. 10. L. Bell and J.A. Madri, Am J Physiol 137 7-12 (1990).
11. 11. M. Stoll, U.M. Stecklings, M. Paul, S.P. Bottari, R. Metzger and T. Unger, J Clin Invest 95 651-657 (1995).
12. 12. R.D. Paula, C.V. Lima, M.C. Khosla and R.A.S. Santos, Hypertension 26 1154-1159 (1995).
13. 13. P. Li, M.C. Chappell, C.M. Ferrario and K.B. Brosnihan, Hypertension 29 394-400 (1997).
14. 14. E.J. Freeman, G.M. Chisolm, C.M. Ferrario and E.A. Tallant, Hypertension 28 104-108 (1996).
15. 15. S.P. Andrade, L.B.G.B. Vieira, Y.S. Bakhle and P.J. Piper, Int J Exp Pathol 73 503-513 (1992).
16. 16. S.P. Andrade, R.D.P. Machado, A.S. Teixeira, A.V. Belo, A.M. Tarso and W.T. Beraldo, Microvasc Res 54 253-261 (1997).
17. 17. M. Rocha E Silva, A.V. Belo, R.D.P. Machado and S.P. Andrade, Inflammation 22 643-651 (1998).
18. 18. T. Mosman, J Immunol Methods 65 55-63 (1983).
19. 19. R.S. Gieni, Y. Li and K.T. Hayglass, Lab Invest 187 85-93 (1995).
20. 20. C.M. Ferrario, Hypertension Res 15 61-66 (1992).
21. 21. R.A.S. Santos and M.J Campagnole-Santos, Braz J Med Biol Res 27 1033-1047 (1994).
22. 22. J.B. Fitzsimons, J Physiol 214 295-303 (1971).
23. 23. I.E. Benter, C.M. Ferrario, M. Morris and D.L. Diz, Am J Physiol 269 H343-349 (1995).
24. 24. L.A. Fernandez, V.J. Casride, J. Twickler and R.E. Galardy, Am J Physiol 243 H869-875 (1982).
25. 25. A. Bobik and J.H. Campbell, Pharmacol Rev 45 1-42 (1993).
26. 26. R. Ross, Nature 362 801-809 (1993).
27. 27. B. Waeber and H.R. Brunner, J Cardiovasc Pharmacol 27 (Suppl 2) S36-S40 (1996).
28. 28. D.H. Munzenmaier and A.S. Greene, Hypertension 27 759-765 (1996).
29. 29. A. Bobik, S. Grinpukel, P.J. Little, A. Groms and G. Jackman, Biochem Biophys Res Commun 166 580-588 (1990).
30. 30. H. Itoh, M. Mukoyama, R.E. Pratt and V.J. Dzau, J Clin Invest 91 2268-2274 (1993).
31. 31. G.A. Stouffer and G.K. Owens, Circ Res 70 820-828 (1992).
32. 32. D.A. Walsh, D.E. Hu, J. Wharton, J.D. Catravas, D.R. Blake and TPD Fan, Br J Pharmacol 120 1302-1311 (1997).
33. 33. M. Viswanathan and J.M. Saavedra. Peptides 13 783-786 (1992).
34. 34. S. Tisuzuki, S. Eguchi and T. Inagami. Biochem Biophys Res Commun 288 825-830 (1996).
35. 35. G. Nickenig, G. Geisen, H. Vetter and A. Sachinidis, J Mol Med 75 217-222 (1997).
36. 36. M. Neub, V. Regitz-Zagrosck, A. Hildebrant and D. Fleck, Biochem Biophys Res Commun 204 132-137 (1995).
37. 37. E. Sakkoula, E. Pipili-Synetos and M.E. Maragoudakis, Br J Pharmacol 122 793-795 (1997).
38. 38. U.C. Garg and A. Hassid, J Clin Invest 83 1774-1777 (1989).
39. 39. P. Shirotani, Y. Yui, R. Hattori and C. Kawai, Prostaglandins 41 97-100 (1991).
40. 40. J. Nilsson and A.G. Olsson, Atherosclerosis 54 77-82 (1984).
41. 41. I.F. Benter, D.I. Diz and C.M. Ferrario, FASEB J 6 A1735 (1992).
42. 42. S.Y. Osei, R.S. Ahima, R.K. Minkes, J.P. Weaver, M.C. Khosla and P.J. Kadowitz, Eur J Pharmacol 234 35-42 (1993).
43. 43. I.A. Reid, B.J. Morris and W.F. Ganong. Annu Rev Physiol 40 377-395 (1978).
44. 44. R.A.S. Santos, J.M. Brum, K.B. Brosnihan and C.M. Ferrario. Hypertension 15 I-121-I-127 (1990).